Cargando…

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?

Detalles Bibliográficos
Autor principal:	Vavlukis, Marija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2017
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864979/ https://www.ncbi.nlm.nih.gov/pubmed/28321108 http://dx.doi.org/10.14744/AnatolJCardiol.2016.23434

Ejemplares similares

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd
por: Shapiro, Michael D., et al.
Publicado: (2020)

Commentary: Increased Risk of Cardiovascular Disease in Restless Legs Syndrome Patients: A Call to Action
por: De Berardis, Domenico, et al.
Publicado: (2023)

Fitness and reduced risk of hypertension—approaching causality
por: Laukkanen, Jari A., et al.
Publicado: (2021)

Postprandial Lipoproteins and Cardiovascular Disease Risk in Diabetes Mellitus
por: Enkhmaa, Byambaa, et al.
Publicado: (2010)

Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitus
por: Moon, Min Kyong
Publicado: (2016)

Lipoprotein (a): A Frustrating Final Frontier in Lipid Management?
por: Libby, Peter
Publicado: (2016)

Type 1 diabetes mellitus and atrial function: A complex relationship
por: Tadic, Marijana, et al.
Publicado: (2016)

Aortic stiffness in type-1 diabetes mellitus; beware of hypertension
por: van der Wall, E. E., et al.
Publicado: (2011)

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction
por: Enas, Enas A., et al.
Publicado: (2019)

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Arterial function and cardiovascular risk in dialysis
por: Iorio, Biagio R Di, et al.
Publicado: (2015)

Megalin/lipoprotein receptor-related protein 2 autoimmunity and kidney disease
por: Perez-Gomez, Maria V, et al.
Publicado: (2020)

Should ethnicity be included in cardiovascular risk stratification?
por: Krenning, B. J., et al.
Publicado: (2014)

Pokémon Go: cardiovascular benefit or injury risk?
por: Sharma, Pranev, et al.
Publicado: (2016)

Lipoprotein (a), an independent cardiovascular risk marker
por: Saeedi, Ramesh, et al.
Publicado: (2016)

The metagenomic approach and causality in virology
por: Castrignano, Silvana Beres, et al.
Publicado: (2015)

Lipoprotein(a): A Taxi for Autotaxin Takes a Toll in Calcific Aortic Valve Disease
por: Towler, Dwight A.
Publicado: (2017)

Risk Evaluation Requires an Independent Mind
por: Schmidt, Christian, et al.
Publicado: (2017)

Lipoprotein (a): A Novel Cardiovascular Risk Factor
por: Kozarova, Miriam, et al.
Publicado: (2023)

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
por: Ortiz, Alberto, et al.
Publicado: (2022)

COVID-19 and acute pancreatitis: examining the causality
por: de-Madaria, Enrique, et al.
Publicado: (2020)

Increased cardiovascular mortality in African Americans with COVID-19
por: McGonagle, Dennis, et al.
Publicado: (2020)

Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?
por: Floyd, Lauren, et al.
Publicado: (2022)

How does diabetes mellitus impact on the prognosis of dental implants?
por: Baniulyte, Gabriele, et al.
Publicado: (2023)

Cardiovascular risks of climate change
por: Peters, Annette, et al.
Publicado: (2020)

Klotho: a link between cardiovascular and non-cardiovascular mortality
por: Lanzani, Chiara, et al.
Publicado: (2020)

Insulin may increase disease severity and mortality of COVID-19 through Na(+)/H(+) exchanger in patients with type 1 and type 2 diabetes mellitus
por: Cure, E., et al.
Publicado: (2022)

Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
por: Tada, Hayato, et al.
Publicado: (2019)

Causality in dietary interventions—building a case for gut microbiota
por: Lam, Yan Y., et al.
Publicado: (2018)

Causal associations between disorders of lipoprotein metabolism and ten cardiovascular diseases
por: Gao, Qiannan, et al.
Publicado: (2022)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Comment on: Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review
por: Hassan, Sherif T. S., et al.
Publicado: (2020)

YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease
por: Schernthaner, Gerit-Holger, et al.
Publicado: (2016)

Tyrosine kinase inhibitor-induced hypertension—marker of anti-tumour treatment efficacy or cardiovascular risk factor?
por: Ptinopoulou, Anastasia G., et al.
Publicado: (2020)

Angiotensin-(1–7) as a biomarker of childhood obesity: Is there a causal relationship?
por: Nozato, Yoichi, et al.
Publicado: (2021)

Is Increased Aortic Stiffness Associated with Advanced Ischemic Stroke?
por: Cho, Eun Joo
Publicado: (2013)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
por: Toth, Peter P
Publicado: (2016)

Sleep Disorder and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus
por: Seo, Mi-Hae, et al.
Publicado: (2011)

Modern causal inference approaches to investigate biodiversity-ecosystem functioning relationships
por: Runge, Jakob
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_njk91q5vkd9q089amvj4ed15mm